Have your own idea? Try our Stock Screener
UPDATED Nov 22, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ABBV | US$176.95 | 3.0% | 27.6% | US$303.5b | US$204.74 | PE61.5x | E28.1% | 3.7% | ||
PFE | US$25.65 | 2.1% | -15.9% | US$142.4b | US$32.55 | PE34x | E16.8% | 6.5% | ||
AMGN | US$294.53 | 1.6% | 11.0% | US$155.8b | US$334.06 | PE37.4x | E19.1% | 3.1% | ||
BMY | US$58.87 | 1.1% | 18.3% | US$118.1b | US$59.37 | PS2.5x | E48.6% | 4.1% | ||
BNTX | US$113.13 | 4.5% | 14.5% | US$25.9b | US$136.49 | PS8.6x | E12.0% | n/a | ||
MRNA | US$41.11 | 7.5% | -47.6% | US$14.7b | US$77.55 | PS3.1x | E17.9% | n/a | ||
TEM | US$58.60 | 11.7% | n/a | US$8.3b | US$57.14 | PS14.4x | E66.6% | n/a | ||
IQV | US$201.82 | 2.1% | -4.8% | US$35.9b | US$254.40 | PE26.1x | E13.8% | 0% | ||
DHR | US$235.84 | 0.3% | 6.5% | US$169.8b | US$290.13 | PE43.3x | E14.0% | 0.4% | ||
GILD | US$90.19 | 0.5% | 19.6% | US$111.9b | US$96.89 | PE892.1x | E40.7% | 3.4% | ||
ROIV | US$12.53 | 6.0% | 37.2% | US$8.6b | US$16.21 | PE2x | E-46.3% | n/a | ||
A | US$133.84 | 1.3% | 5.7% | US$37.9b | US$150.11 | PE27.2x | E4.1% | 0.7% | ||
ILMN | US$140.14 | 2.3% | 42.5% | US$21.7b | US$164.60 | PS5.1x | E70.4% | 2.2% | ||
MTD | US$1,217.97 | 1.8% | 11.4% | US$25.3b | US$1,327.93 | PE32.3x | E7.6% | n/a | ||
ASND | US$129.81 | 5.8% | 40.7% | US$7.3b | US$191.58 | PS22.8x | E71.4% | n/a | ||
SMMT | US$19.00 | 3.1% | 850.0% | US$13.6b | US$34.27 | PB32x | S85.4% | n/a | ||
HALO | US$49.00 | 7.2% | 21.3% | US$5.8b | US$62.44 | PE15.9x | E21.1% | n/a | ||
MDGL | US$347.45 | 5.5% | 77.7% | US$7.2b | US$372.20 | PS98.7x | E73.1% | n/a | ||
APLS | US$30.77 | 10.9% | -36.4% | US$3.5b | US$45.75 | PS5.4x | E72.1% | n/a | ||
SRPT | US$114.23 | 3.4% | 37.8% | US$10.6b | US$189.62 | PE89.5x | E42.6% | n/a | ||
SRRK | US$29.92 | 12.2% | 154.9% | US$2.5b | US$39.88 | PB35.4x | E48.8% | n/a | ||
WAT | US$373.47 | 1.3% | 33.2% | US$21.9b | US$375.45 | PE35.6x | E8.6% | n/a | ||
PTGX | US$46.46 | 11.5% | 169.6% | US$2.5b | US$56.38 | PE16.2x | E-31.4% | n/a | ||
AVTR | US$20.78 | 2.1% | 2.3% | US$13.9b | US$27.31 | PE45.7x | E36.4% | n/a |